Department of Obstetrics and Gynecology, Lyon 1 University, Lyon Hospital, Lyon Sud University Hospital, Lyon, France.
Hum Reprod. 2011 Oct;26(10):2651-7. doi: 10.1093/humrep/der265. Epub 2011 Aug 12.
To evaluate the contribution of referent pathologists (RPs) to the quality of diagnosis of trophoblastic diseases and to study the level of diagnostic agreement between the initial pathologists and the RPs.
This observational retrospective study was carried between 1 November 1999 and 11 January 2011 using the database of the French Trophoblastic Disease Reference Centre in Lyon. All files for hydatiform moles (HMs), trophoblastic tumours and non-molar pregnancies for which there was an initial suspicion of trophoblastic disease were included, whenever there was rereading of the slides by an RP. A total of 1851 HMs and 150 gestational trophoblastic tumours were analysed.
When the initial pathologist diagnosed a complete mole, the RP confirmed the diagnosis in 96% of cases. When the initial pathologist diagnosed a partial mole, the RP confirmed the diagnosis in only 64% of cases. For trophoblastic tumours, when the initial pathologist diagnosed a choriocarcinoma, the RP confirmed the diagnosis in 86% of cases. When the initial anatomopathology suggested an invasive mole, the diagnosis was confirmed in 96% of cases. Finally, when the initial diagnosis was a placental site trophoblastic tumour or an epithelioid trophoblastic tumour, the RP confirmed the diagnosis in 60 and 100% of cases, respectively.
A systematic policy of rereading of slides for all suspicious moles improves the quality of management of trophoblastic diseases at a national level.
评估参考病理学家(RPs)对滋养细胞疾病诊断质量的贡献,并研究初始病理学家与 RPs 之间诊断一致性的水平。
本观察性回顾性研究于 1999 年 11 月 1 日至 2011 年 1 月 11 日在法国里昂滋养细胞疾病参考中心的数据库中进行。所有包括葡萄胎(HM)、滋养细胞肿瘤和非葡萄胎妊娠的文件,只要有 RPs 重新阅读切片,都被包括在内。共分析了 1851 例 HM 和 150 例妊娠滋养细胞肿瘤。
当初始病理学家诊断为完全性葡萄胎时,RPs 在 96%的病例中确认了诊断。当初始病理学家诊断为部分性葡萄胎时,RPs 在仅 64%的病例中确认了诊断。对于滋养细胞肿瘤,当初始病理学家诊断为绒毛膜癌时,RPs 在 86%的病例中确认了诊断。当初始解剖病理学提示侵袭性葡萄胎时,诊断在 96%的病例中得到确认。最后,当初始诊断为胎盘部位滋养细胞肿瘤或上皮样滋养细胞肿瘤时,RPs 在 60%和 100%的病例中分别确认了诊断。
对所有可疑葡萄胎进行系统性的重新阅读切片政策,可提高全国滋养细胞疾病管理的质量。